Noticias y Eventos
Screening for Atrial Fibrillation Using Smartphones and Smartwatches
Smartphones and smartwatches are used for a multitude of purposes in our daily lives. They are equipped with sensors that may monitor our patients’ health. This article provides an overview on how they may be used to screen for atrial fibrillation, and discusses the current status of this technology.
The GRASP suite of tools and future continuity
PRIMIS CHART users may already be aware that the current sponsors of the GRASP suite, NHS England Sustainable Improvement Team, will cease their funding and support for the four tools from 1st April 2018. We thank the team for their support over the years and wish them every success in the future.
A Nationwide Trail of Screening for Undiagnosed Atrial Fibrillation in an At-Risk Population Using a Self-Applied ECG Recording Patch Sensor
Results from the randomized component of the mHealth Screening to Prevent Strokes.
Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation
Barcelona, Spain – 20 March 2018: Apixaban and warfarin are equally safe during catheter ablation of atrial fibrillation, according to results of the AXAFA-AFNET 5 trial presented today in a late-breaking trial session at EHRA 2018, a European Society of Cardiology (ESC) congress.1 There were similar ...
New Analyses Confirm Patients with Medtronic CRT Devices Experience Less Atrial Fibrillation ...
DUBLIN and BARCELONA, Spain - March 20, 2018 - Two real-world analyses featuring the Medtronic plc (NYSE: MDT) AdaptivCRT(TM) algorithm reinforce that its use is linked to a reduction in atrial fibrillation (AF) episodes, as well as tied to higher patient activity levels. The results, involving 408 ...
Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation
DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF). The Arctic Front Advance Cyroablation System is not approved for treating persistent AF in the United States.
Stroke prevention drugs may help reduce dementia risk for atrial fibrillation patients
Barcelona, Spain – 18 March 2018: Patients with atrial fibrillation could reduce the risk of dementia by taking stroke prevention medications, according to recommendations published online today in EP Europace1, a European Society of Cardiology journal, and presented at EHRA 2018.2 The international consensus document was also published in Heart Rhythm, the official journal of the Heart Rhythm Society (HRS), and Journal of Arrhythmia, the official journal of the Japanese Heart Rhythm Society (JHRS) and the Asia Pacific Heart Rhythm Society (APHRS).
Drinking alcohol makes your heart race
Barcelona, Spain – 18 March 2018: The more alcohol you drink, the higher your heart rate gets, according to research presented today at EHRA 2018 Congress1, organized by the European Society of Cardiology.
Cardiac Rhythm News - 16 March 2018
Get the latest Cardiac Rhythm News here.
European Journal of Arrhythmia & Electrophysiology - Volume 4 Issue 1 - Summer 2018
We would like to welcome you to the summer edition of the European Journal of Arrhythmia & Electrophysiology. This edition includes a timely and pertinent editorial from Haran Burri, who looks at the impact of smart technology on screening for atrial fibrillation. We also have an original research article from Erik Wissner et al., who have conducted a study of noninvasive versus invasive mapping of atrial flutter.